A Study of Efgartigimod PH20 SC in Adults With Thyroid Eye Disease
Condition(s):Thyroid Eye DiseaseLast Updated:March 13, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Thyroid Eye DiseaseLast Updated:March 13, 2024Not yet recruiting
Condition(s):Primary Sjogren Syndrome; Secondary Sjogren Syndrome; Aqueous Deficient Dry Eye Disease; Evaporative Dry Eye DiseaseLast Updated:September 22, 2020Completed
Condition(s):Eye DiseasesLast Updated:December 16, 2019Completed
Condition(s):Thyroid-associated OphthalmopathyLast Updated:January 1, 2016Completed
Condition(s):Thyroid Eye DiseaseLast Updated:March 22, 2024Recruiting
Condition(s):Dry Eye DiseaseLast Updated:September 11, 2023Not yet recruiting
Condition(s):Dry Eye SyndromesLast Updated:May 27, 2022Active, not recruiting
Condition(s):Pulmonary Fibrosis; Thyroid Eye DiseaseLast Updated:March 4, 2024Recruiting
Condition(s):Dry Eye DiseaseLast Updated:February 13, 2023Not yet recruiting
Condition(s):Dry EyeLast Updated:January 8, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.